Health Care & Life Sciences » Pharmaceuticals | Tianjin Tianyao Pharmaceutical Co. Ltd.

Tianjin Tianyao Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
51,998.60
86,723.90
78,807.60
136,467.60
162,434.30
196,963.40
Depreciation, Depletion & Amortization
69,028.20
69,040.60
69,601.40
94,767.80
99,339.70
109,432
Other Funds
502,450.70
-
16,132.10
20,204.70
10,321.80
93,126.60
Funds from Operations
155,554.50
132,590.60
155,628.00
233,617.20
297,199.90
394,893.90
Changes in Working Capital
70,694.30
24,186.50
22,755.90
172,897.60
300,087.60
197,236.20
Net Operating Cash Flow
84,860.20
156,777.10
132,872.10
60,719.70
2,887.70
197,657.70
Capital Expenditures
310,178.00
16,779.60
45,323.60
79,666.10
120,597.50
Sale of Fixed Assets & Businesses
-
-
-
2.80
2,557.40
Purchase/Sale of Investments
-
10,060.30
149,158.90
-
3,872.30
Net Investing Cash Flow
209,126.60
36,801.90
194,482.50
70,336.70
109,767.80
Cash Dividends Paid - Total
10,857.80
17,295.40
26,903.90
-
20,178.00
Issuance/Reduction of Debt, Net
27,158.30
131,036.30
10,493.40
67,837.60
4,959.60
Net Financing Cash Flow
464,434.60
148,331.70
32,542.60
88,042.40
35,459.30
Net Change in Cash
334,104.00
29,453.80
83,169.90
52,226.00
156,626.50
Free Cash Flow
225,317.80
139,997.50
87,548.50
18,946.40
123,485.20
Deferred Taxes & Investment Tax Credit
772.90
351.40
416.10
8,165.00
1,364.30
4,628
Other Sources
101,051.40
-
-
150,000.00
4,400.00
Exchange Rate Effect
6,064.20
1,097.30
10,983.10
9,211.90
8,511.70
Other Uses
-
9,962.00
-
-
-

About Tianjin Tianyao Pharmaceutical Co.

View Profile
Address
No.19, Xinye 9th Street
Tianjin Tianjin 300462
China
Employees -
Website http://www.kingyork.biz/tianyaoyaoye/
Updated 07/08/2019
Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the development, manufacture, distribution, and export of raw materials used for the manufacture of medicines, small capacity injections, and medicinal preparations. Its products include corticosteroids and cardiovascular medicine, dexamethasone, and cortisone acetate. The company was founded on December 1, 1999 and is headquartered in Tianjin, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.